Pilot study of recombinant human granulocyte‐macrophage colony–stimulating factor in the treatment of chronic hepatitis B
暂无分享,去创建一个
[1] Lieschke Gj,et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). , 1992, The New England journal of medicine.
[2] A. Burgess,et al. Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor , 1992 .
[3] D. S. Webb,et al. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido- 2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine , 1989, The Journal of experimental medicine.
[4] M. Andreeff,et al. Hematopoietic colony-stimulating factors. , 1989, Seminars in oncology.
[5] J. Hoofnagle,et al. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B , 1988 .
[6] M. Peters,et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. , 1988, Annals of internal medicine.
[7] J. Gutterman,et al. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. , 1988, Cancer research.
[8] G. Alexander,et al. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. , 1988, Gastroenterology.
[9] V. Carreño,et al. COMBINATION OF RECOMBINANT INTERFERONS ALPHA AND GAMMA IN TREATMENT OF CHRONIC HEPATITIS B , 1987, The Lancet.
[10] Heather M. Smith,et al. Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection , 1993, Journal of medical virology.
[11] T. Ikeda,et al. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life , 1986, Hepatology.
[12] J. Hoofnagle. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate. , 1986, Journal of hepatology.
[13] S. Thung,et al. Molecular and cellular pathology of hepatitis B. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[14] Z. Varghese,et al. Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. , 1983, The Journal of antimicrobial chemotherapy.
[15] J. Houglum. Interferon: mechanisms of action and clinical value. , 1983, Clinical pharmacy.
[16] Iversen Ll. Neurotransmitters and CNS disease. Introduction. , 1982 .
[17] I. Cobden,et al. 初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .
[18] J. Gerin,et al. An assay for the detection of the dna genome of hepatitis b virus in serum , 1982, Journal of Medical Virology.
[19] A. McKendrick,et al. DENTAL CARIES AND SUGAR INTAKE , 1975, The Lancet.